Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jan;49(1):15-27.
doi: 10.1111/jcpe.13564. Epub 2021 Oct 28.

Adjunctive benefits of systemic metronidazole on non-surgical treatment of peri-implantitis. A randomized placebo-controlled clinical trial

Affiliations
Randomized Controlled Trial

Adjunctive benefits of systemic metronidazole on non-surgical treatment of peri-implantitis. A randomized placebo-controlled clinical trial

Carlota Blanco et al. J Clin Periodontol. 2022 Jan.

Abstract

Aim: To study clinical, radiographic, and microbiological outcomes after non-surgical therapy of peri-implantitis with or without adjunctive systemic metronidazole.

Materials and methods: A randomized placebo-controlled clinical trial was carried out in 32 subjects (62 implants) diagnosed with peri-implantitis. Implants received a mechanical non-surgical debridement session and systemic metronidazole or placebo. Clinical, radiographic, and microbiological outcomes were evaluated at baseline, 3, 6, and 12 months.

Results: After 12 months, the test treatment resulted in significantly greater PPD reduction (2.53 vs. 1.02 mm) and CAL gain (2.14 vs. 0.53 mm) (p value <.05) in comparison with placebo. The test treatment also resulted in additional radiographic bone gain (2.33 vs. 1.13 mm) compared with placebo (p value <.05). There was a significantly greater decrease in Porphyromonas gingivalis, Tannerella forsythia, and Campylobacter rectus counts compared with the control group (p value <.05). At the end of follow-up, 56.3% of patients met the success criteria in the test group and 25% in the control group.

Conclusions: The use of systemic metronidazole as an adjunct to non-surgical treatment of peri-implantitis resulted in significant additional improvements in clinical, radiographic, and microbiological parameters after 12 months of follow-up. This study is registered in ClinicalTrials.gov (NCT03564301).

Keywords: antibiotic; metronidazole; non-surgical; peri-implantitis; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Berglundh, T., Armitage, G., Araujo, M. G., Avila-Ortiz, G., Blanco, J., Camargo, P. M., & Zitzmann, N. (2018). Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. Journal of Periodontology, 89(Suppl 1), S313-S318. https://doi.org/10.1002/JPER.17-0739
    1. Berglundh, T., Zitzmann, N. U., & Donati, M. (2011). Are peri-implantitis lesions different from periodontitis lesions? Journal of Clinical Periodontology, 38(Suppl 11), 188-202. https://doi.org/10.1111/j.1600-051X.2010.01672.x
    1. Carcuac, O., Abrahamsson, I., Albouy, J. P., Linder, E., Larsson, L., & Berglundh, T. (2013). Experimental periodontitis and peri-implantitis in dogs. Clinical Oral Implants Research, 24(4), 363-371. https://doi.org/10.1111/clr.12067
    1. Carcuac, O., Derks, J., Charalampakis, G., Abrahamsson, I., Wennström, J., & Berglundh, T. (2016). Adjunctive systemic and local antimicrobial therapy in the surgical treatment of peri-implantitis: A randomized controlled clinical trial. Journal of Dental Research, 95(1), 50-57. https://doi.org/10.1177/0022034515601961
    1. Charalampakis, G., & Belibasakis, G. N. (2015). Microbiome of peri-implant infections: Lessons from conventional, molecular and metagenomic analyses. Virulence, 6(3), 183-187. https://doi.org/10.4161/21505594.2014.980661

Publication types

Associated data

LinkOut - more resources